|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0205179,
umls-concept:C0205390,
umls-concept:C0392920,
umls-concept:C0442711,
umls-concept:C0685938,
umls-concept:C0701185,
umls-concept:C0854750,
umls-concept:C1257890,
umls-concept:C1446539,
umls-concept:C2603343
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-8-27
|
|
pubmed:abstractText |
The primary objective of this study was to explore the efficacy and safety of combined chemotherapy with CPT-11 and UFT in patients with advanced/metastatic colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1465-3621
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
521-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17720738-Adenocarcinoma,
pubmed-meshheading:17720738-Administration, Oral,
pubmed-meshheading:17720738-Adolescent,
pubmed-meshheading:17720738-Adult,
pubmed-meshheading:17720738-Aged,
pubmed-meshheading:17720738-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17720738-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17720738-Camptothecin,
pubmed-meshheading:17720738-Colorectal Neoplasms,
pubmed-meshheading:17720738-Humans,
pubmed-meshheading:17720738-Infusions, Intravenous,
pubmed-meshheading:17720738-Middle Aged,
pubmed-meshheading:17720738-Neoplasm Recurrence, Local,
pubmed-meshheading:17720738-Tegafur,
pubmed-meshheading:17720738-Uracil
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase I/II study of CPT-11 plus UFT in patients with advanced/recurrent colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Protocol 0102.
|
|
pubmed:affiliation |
Department of Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan. ntomita@hyo_med.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
